27 research outputs found
Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome
AbstractBackgroundPregnancy failure and placenta mediated pregnancy complications affect >25% of pregnancies. Although there is biological plausibility for a procoagulant mechanism underlying some of these events, antithrombotic intervention trials demonstrate limited benefit, possibly through lack of stratification in heterogeneous patient groups. The ANXA5 M2 haplotype is a possible procoagulant biomarker and was tested pragmatically to determine whether this screening and LMWH treatment normalized the outcome for ANXA5 M2 positive couples.This was a pragmatic study that aimed to measure the effectiveness of a testing (for the M2 haplotype) and treatment (LMWH) pathway in routine clinical practice where there is variation between patients. Such a study in couples with fertility problems can inform choices between treatments; it is then the management protocol which is the subject of the investigation, not the individual treatments.MethodsCouples (N=77) with one or both partners ANXA5 M2 positive demonstrated association of this haplotype with adverse IVF outcome. A pragmatic, multicenter, prospective cohort study of ANXA5 M2 haplotype screening, and LWMH treatment following embryo transfer (ET) in 103 IVF couples positive for ANXA5 M2 was performed. They were compared with a group of 1000 contemporaneous randomly selected unscreened and untreated couples undergoing assisted conception, from which 103 matched control couples were derived. The primary outcome measure was live birth incidence. Secondary outcomes were results following embryo transfer (ET) and live birth outcome by gender and M2 carriage, and allelic dose influence.FindingsThe tested and treated cohort of ANXA5 M2 carriers achieved a similar live birth rate (37.9%) per ET cycle compared to both the more fertile comparison group (38.5%), and to the 103 matched controls (33.0%). Significantly more treated male carrier only couples had a live birth versus female M2 only (47.7% vs. 25.0% p=0.045).InterpretationPragmatic ANXA5 M5 screening and treatment with LMWH in couples undergoing IVF is associated with similar outcome to couples with more favorable prognostic factors. The difference in live birth outcome for treated male only carrier couples may be consistent with an additional maternal thrombophilic factor that may adversely affect pregnancy, although other mechanisms are possible. This study suggests that LMWH treatment should be started prior to clinical pregnancy
Continuing to deliver: the evidence base for pre-implantation genetic screening
International audienc
Localisation and Function of the Endocannabinoid System in the Human Ovary
Although anandamide (AEA) had been measured in human follicular fluid and is suggested to play a role in ovarian follicle and oocyte maturity, its exact source and role in the human ovary remains unclear.Immunohistochemical examination of normal human ovaries indicated that the endocannabinoid system was present and widely expressed in the ovarian medulla and cortex with more intense cannabinoid receptor 2 (CB2) than CB1 immunoreactivity in the granulosa cells of primordial, primary, secondary, tertiary follicles, corpus luteum and corpus albicans. The enzymes, fatty acid amide hydrolase (FAAH) and N-acyclphosphatidylethanolamine-phospholipase D (NAPE-PLD), were only found in growing secondary and tertiary follicles and corpora lutea and albicantes. The follicular fluid (FF) AEA concentrations of 260 FF samples, taken from 37 infertile women undergoing controlled ovarian hyperstimulation for in vitro fertilisation and intracytoplasmic sperm injection with embryo transfer, were correlated with ovarian follicle size (P = 0.03). Significantly higher FF AEA concentrations were also observed in mature follicles (1.43+/-0.04 nM; mean+/-SEM) compared to immature follicles (1.26+/-0.06 nM), P = 0.0142 and from follicles containing morphologically assessed mature oocytes (1.56+/-0.11 nM) compared to that containing immature oocytes (0.99+/-0.09 nM), P = 0.0011. ROC analysis indicated that a FF AEA level of 1.09 nM could discriminate between mature and immature oocytes with 72.2% sensitivity and 77.14% specificity, whilst plasma AEA levels and FF AEA levels on oocyte retrieval day were not significantly different (P = 0.23).These data suggest that AEA is produced in the ovary, is under hormonal control and plays a role in folliculogenesis, preovulatory follicle maturation, oocyte maturity and ovulation
The use of ultrasound and biochemical markers in prediction of pregnancy outcome
EThOS - Electronic Theses Online ServiceGBUnited Kingdo
The use of ultrasound and biochemical markers in prediction of prgnancy outcome
The aims of this thesis were to develop novel approaches to the management of early pregnancy complications and to identify a subgroup of women who develop various pregnancy complications in the second and third trimester. The thesis is based on four studies of women in the first trimester of pregnancy. These studies examine the value of ultrasound and serum biochemistry in the prediction of outcome in women with an anembryonic gestational sac (Chapter 4), with ectopic pregnancies (Chapter 5), with failing pregnancies (Chapter 6) and women developing later complications (Chapter 7). Statistical models comprising of logistic regression or decision tree analysis were developed for each study. In women with anembryonic gestation sacs the probability of a viable pregnancy can be calculated using a logistic regression model, decision tree analysis or progesterone alone with equal accuracy. These models were validated prospectively. Decision tree analysis was used to develop a model for the prediction of successful expectant management of ectopic pregnancy, based on both a single serum hCG measurement or using serial measurement. These models were also validated prospectively. A novel approach to the prediction of the success of expectant management of miscarriages was developed using decision tree analysis and IGFBP-1 and inhibin A. A raised serum value of 17 OH progesterone appeared to identify those women at risk of developing hypertensive disorders later in pregnancy. This thesis has developed algorithms that can be used in clinical practise to predict the success of expectant management in women with failing pregnancies. It has identified that novel biochemical markers may have a role to play in the prediction of successful expectant management of women with miscarriages and the prediction of pregnancy complications developing in the second and third trimesters